Premier European Meeting of the Society of Biomolecular Imaging and Informatics (SBI2)

We are delighted to invite you to the first European meeting of the Society of Biomolecular Imaging and Informatics (SBI2),
held in Cambridge, UK on July 7th – 8th, 2026

Program Overview

We are excited to have Dr Fabian Theis and Dr Andreas Bender as our Keynote speakers for the European SBI2 2026 conference. 

🔹 Prof. Dr. Dr. Fabian Theis
Prof. Dr. Dr. Fabian Theis heads the Helmholtz Munich Computational Health Center and holds the Chair for Mathematical Models of Biological Systems at the Technical University of Munich. His research pioneers machine‑learning frameworks, scalable inference methods, and foundation models that integrate multimodal single‑cell and spatial omics data, enabling a deeper understanding of cellular decision‑making, tissue organization, and disease mechanisms. 

🔹 Dr. Andreas Bender
Professor for Machine Learning in Medicine at the Department of Medicine at Khalifa University, Abu Dhabi, analyzing heterogenous chemical, biological and medical data. Before this post, he has been Professor for Molecular Informatics at Cambridge University and a Director for Digital Life Sciences at Nuvisan/Berlin, as well as Associate Director for Data Science and AI in the Clinical Pharmacology & Safety Sciences group at AstraZeneca/Cambridge, UK.

Scientific Sessions

Session 1: Simulating Life: The Virtual Cell Revolution Chair: Peter Horvath, Helmholtz Munich

The virtual cell is no longer science fiction: this session presents three complementary advances towards in silico biology — predicting how perturbations propagate from single cells to spatial tissue contexts, measuring thousands of proteins per cell at scale, and fusing morphological imaging with proteomics to capture the full phenotypic fingerprint of a cell.

Session 2: Silicon Meets Cell: AI Seeing What We Can’t Chair: Bolek Zapiec, Merck KgaA

Images of cells encode far more biological information than the eye can see, this session demonstrates how deep learning and AI-powered image analysis are decoding that hidden language, from single-cell phenotyping and microenvironment-aware classification to mechanism-of-action inference and drug discovery.

Session 3: The Future is Now: Next-Wave High-Content Technologies Chair: Anusuya Banerjee,GSK
This session showcases the cutting edge of high-content screening hardware, software, and methodology — opening with the HCS-3DX platform, which brings light-sheet fluorescence microscopy and AI-driven single-cell analysis to 3D cell cultures including spheroids and organoids, unlocking a dimension of biological information inaccessible to conventional 2D screening systems.

Session 4: Image to Impact: High-Content Screening Delivered Chair: Morag Rose Hunter, Astra Zeneca

This session explores how high-content screening converts images into actionable insights that drive decision-making in real-world projects.

Session 5: Dimension Matters: Revolutionizing Drug Discovery in 3D Chair: Neil Carragher,University of Edinburgh
This session will encompass presentations describing cutting-edge high content imaging applications to map spatial interactions between cells with their 3-dimensional microenvironment. Presentations will describe new tools which combine with high content imaging to optimally exploit and scale complex human in vitro 3D models of disease incorporating human iPSC-derived co-culture and organoid models.

Educations session:

The education session led by expert speakers provides a practical roadmap for high-content screening, from foundational assay design to advanced AI-driven discovery. Attendees will gain the strategic insights needed to bridge the gap between wet-lab execution and complex computational modeling.

Agenda – Day 1 

TimePresenterTitle
Education Session
09:00-10:00Jordi Carreras-Puigvert,
Pixl Bio
From Pixels to Profiles: A Practical Guide to High-Content Screening in Drug Discovery
10:00-11:00Adriana Borowa,
Ardigen
Navigating Deep Learning for High Content Image Analysis
11:00-11:30Coffee Break
11:30-12:30Steffen Jaensch,
Johnson & Johnson
From Features to Decisions: Practical Downstream Analysis Strategies for High Content Imaging
12:30-13:30Lunch Break
Session 1Chair: Peter Hovath,
Biological Research Centre, Szegad
Simulating Life: The Virtual Cell Revolution
13:30-14:30Fabian Theis,
Helmholtz Munich
Closing the loop: from single-cell perturbations to spatial interventions
14:30-14:40Plat. SpotlightNikon
14:40-15:10Coffee Break
15:10-15:40Tami Geiger,
Weizmann Institute of Science
Elucidation of Cancer Heterogeneity through Deep Visual Proteomics
15:40-16:10Bolek Zapiec,
Merck Healthcare
Painting a Better Picture: Multimodal Approaches with Cell painting and Proteomics
16:10-16:20Selected TalkTBC
16:20-16:25SpotlightGlencoe Software
16:25 + Poster Session and Evening Networking

Agenda – Day 2

TimePresenterTitle
Session 2Chair: Bolek Zapiec,
Merck Healthcare
Silicon Meets Cell: AI Seeing What We Can’t
09:00-10:00Andreas Bender,
Khalifa University
From Cellular Imaging to Decision Making – Approaches and Pitfalls
10:00-10:30Peter Horvath,
HUN-REN Biological Research Centre, Szeged
Life beyond the pixels: single-cell analysis using deep learning and image analysis methods
10:30-10:40Plat. SpotlightPixl Bio
10:40-10:50Selected TalkTBD
10:50-11:15Coffee Break 
Session 3Chair: Anusuya Banerjee,
GlaxoSmithKline
The Future is Now: Next-Wave High Content Technologies
11:15-11:45Akos Diosdi,
HUN-REN Biological Research Centre, Szeged
HCS-3DX: imaging platform for 3-dimensional cell cultures using light-sheet microscopy
11:45-12:15Britt Vervoort, The Princess Máxima Center for Pediatric OncologyBEHAV3D-HIGH THROUGHPUT: A 3D high-content life imaging immuno-oncology assay for immunotherapy screening
12:15-12:20Spotlight TalkSaguaro Biosciences
12:20-12:30Selected TalkTBD
12:35-13:30Lunch Break + Poster Session 
Session 4Chair: Morag Rose Hunter,
AstraZeneca
Image to Impact:High-Content Screening Delivered
13:30-14:00Guido Zagnoli,
AstraZeneca
Seeing Decisions: Embedding Imaging Across the DMTA cascade
14:00-14:30Melanie Sakatis,
GlaxoSmithKline
Use of High Content Imaging in DILIsym QST modelling for regulatory submission
14:30-14:40Plat. Spotlight TalkAraceli Biosciences
14:40-14:50Selected TalkTBD
14:50-15:15 Coffee Break 
Session 5Chair: Neil Carragher,
University of Edinburgh
Dimension Matters:Revolutionising Drug Discovery in 3D
15:15-15:45Ilya Lukonin,
IHB Basel
A toolbox for phenotypic discovery in complex in vitro model systems
15:45-16:15Davide Danovi,
Kings College London
A human iPSC-based neural spheroid platform for modelling glioblastoma infiltration using high-content imaging
16:15-16:20Spotlight TalkZeiss
16:20-16:30Selected TalkTBD
16:30Closing Remarks

We look forward to welcoming you to an exciting event filled with learning, high-level networking, and discovery!

Venue location

 Venue address:
1 Francis Crick Ave, Cambridge CB2 0AA, UK 

Accomodation:

As an attendee, you can book your accommodation in Cambridge at a negotiated rate at the following hotels:

ibis Cambridge Central Station

2 Station Square CB12GA CAMBRIDGE – United Kingdom


Clayton Hotel Cambridge

27-29 Station Rd, Cambridge CB1 2FB, United Kingdom


Register now to receive your promo codes.

SBI2 Premier European Meeting Abstract Submission

We invite you to submit abstracts describing original research on topics relevant to any of the five scientific sessions, for either a poster or a short, 10-minute podium presentation. Abstracts will be assessed based on the novelty of the work, with an emphasis on those that clearly detail results.

Deadlines:

  • Submissions:
    • Podium presentation – April 24th May 7th
    • Poster presentation –  May 7th
  • Confirmation:
    • Podium presentation – May 15th
    • Poster presentation – May 23rd

Attendance Registration

Society members receive a discount on registration. If you are not a current member you can sign up using the membership page, and you will immediately be eligible the discounted rate. Membership also confers ongoing access to recordings of conference presentations and educational sessions.



Online registration open, in person registration available at conference.


Any issues with registration or payment please contact regional@sbi2.org


Why Attend?

SBI2 is an international community of leaders, scientists, and students promoting technological advancement, discovery, and education to quantitatively interrogate biological models to provide high context information at the cellular level. The goal of this inaugural European meeting is to strengthen the local presence of the Society and consolidate the European biomolecular imaging and informatics ecosystem.

Why Exhibit?

This event represents a premier gathering for leaders in high-content imaging, phenotypic screening, and AI-driven discovery. With at least 50% of attendees representing top-tier European pharmaceutical companies, this is a highly targeted forum designed to connect innovators with the technology partners driving the next generation of drug discovery.


In addition to world-class scientific talks and educational courses, the conference features dedicated networking sessions and an evening reception. It provides the ideal environment for strategic visibility, relationship-building, and positioning your brand at the forefront of translational biology and predictive toxicology.

Sponsor and Vendor Information

A huge thank you to the sponsors supporting our first European SBI2 meeting- Your partnership is making this inaugural event possible! 

Platinum Sponsors

Gold Sponsors

Silver Sponsors

We are grateful to EU-OPENSCREEN for sponsoring the poster session and awards, Ardigen for the coffee break, Glencoe software for the spotlight and to the Royal Microscopical Society (RMS) Life Sciences Section for funding the Early Career Researcher Prize for excellence in imaging.

Please note that all main sponsorship packages are sold out. However, if you still wish to support the event, contact us directly at regional@sbi2.org.